Načítá se...
Gene Therapy For Beta-Thalassemia: Updated Perspectives
Allogeneic hematopoietic stem cell transplantation was until very recently, the only permanent curative option available for patients suffering from transfusion-dependent beta-thalassemia. Gene therapy, by autologous transplantation of genetically modified hematopoietic stem cells, currently represe...
Uloženo v:
| Vydáno v: | Appl Clin Genet |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6765258/ https://ncbi.nlm.nih.gov/pubmed/31576160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TACG.S178546 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|